Pharmacokinetics of Selective Estrogen Receptor Modulators
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 42 (4) , 361-372
- https://doi.org/10.2165/00003088-200342040-00004
Abstract
Selective estrogen receptor modulators (SERMs) are a class of compounds used to treat and prevent breast cancer and osteoporosis. SERMs currently approved for use in patients include tamoxifen,...Keywords
This publication has 73 references indexed in Scilit:
- Clinical Pharmacokinetics of ToremifeneClinical Pharmacokinetics, 2000
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- ToremifeneDrugs, 1997
- Clinical Pharmacokinetics of Endocrine Agents Used in Advanced Breast CancerClinical Pharmacokinetics, 1992
- Phase I study of the tolerance and pharmacokinetics of toremifene in patients with cancerBreast Cancer Research and Treatment, 1990
- Pharmacokinetics of toremifeneJournal of Steroid Biochemistry, 1990
- TamoxifenDrugs, 1989
- Life threatening interaction between tamoxifen and warfarin.BMJ, 1989
- Clinical Pharmacokinetics of Drugs Used in the Treatment of Breast CancerClinical Pharmacokinetics, 1988
- The Metabolism of Tamoxifen (I.C.I. 46,474) Part II: In Female PatientsXenobiotica, 1973